why choose us

First received: August 03, 2022

Clinical Trial: Shortened Course Adjuvant Radiotherapy Following TORS

Study Status: Completed

Recruit Status: RECRUITING

Condition: Oropharyngeal Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Shortened Course, Dose De-Intensified Adjuvant Radiotherapy Following Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Brief Summary: This is a single-arm, phase II study to establish the safety of reducing radiation dose in selected p16+ OPSCC patients receiving adjuvant radiation after TORS and neck dissection.This protocol also allows for sparing of the primary resection bed, in appropriate patients, as previously published by our group and found to be safe and effective.

Read more